A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy

Closed

Phase

Abbreviated Title

Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Women with Endocrine Responsive BC

Activated

10/15/2015

Closed

12/31/2019

Participants

ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE

Research committees

Breast Cancer

Cancer Survivorship

Eligibility Criteria Expand/Collapse

Eligibility criteria are accessible from the protocol abstract page on the CTSU website (http://www.ctsu.org).

Publication Information Expand/Collapse

2023

Interrupting Endocrine Therapy to Attempt Pregnancy After Breast Cancer

AH Partridge;S Niman;M Ruggeri;F Peccatori;H Azim;M Colleoni;C Saura;C Shimizu;A Saetersdal;J Kroep;A Mailliez;E Warner;V Borges;F Amant;A Gombos;A Kataoka;C Rousset;S Borstnar;J Takei;J Lee;J Walshe;M Ruiz Borrego;HCF Moore;C Saunders;V Bjelic-Radisic;S Susnjar;F Cardoso;K Smith;T Ferreiro;K Ribi;K Ruddy;R Kammler;S El-Abed;G Viale;M Piccart;L Korde;A Goldhirsch;R Gelber;O Pagani New England Journal of Medicine May 4;388(18):1645-1656

PMid: PMID37133584 | PMC number: PMC10358451

Other Clinical Trials

SWOG Clinical Trial Number

S1501

Prospective Evaluation of Carvedilol vs No treatment in Prevention of Cardiac Dysfunction in Patients with Metastatic HER-2+ Breast Cancer.

Research Committee(s)

Cancer Survivorship

Breast Cancer

Activated

09/15/2017

Accrual

38%

Open

Phase